Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189


Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon.

Youngpairoj AS, Alemnji GA, Eno LT, Lyonga EJ, Eloundou MA, Shanmugam V, Mpoudi EN, Folks TM, Kalish ML, Pieniazek D, Fonjungo PN.

AIDS Res Hum Retroviruses. 2012 Jul;28(7):675-84. doi: 10.1089/AID.2011.0181. Epub 2011 Nov 14.


AIDS animal model comes of age.

Folks TM.

J Med Primatol. 2011 Feb;40(1):59-60. doi: 10.1111/j.1600-0684.2010.00460.x. Epub 2010 Nov 30. No abstract available.


Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.

García-Lerma JG, Cong ME, Mitchell J, Youngpairoj AS, Zheng Q, Masciotra S, Martin A, Kuklenyik Z, Holder A, Lipscomb J, Pau CP, Barr JR, Hanson DL, Otten R, Paxton L, Folks TM, Heneine W.

Sci Transl Med. 2010 Jan 13;2(14):14ra4. doi: 10.1126/scitranslmed.3000391.


Resources for genetic management and genomics research on non-human primates at the National Primate Research Centers (NPRCs).

Kanthaswamy S, Capitanio JP, Dubay CJ, Ferguson B, Folks T, Ha JC, Hotchkiss CE, Johnson ZP, Katze MG, Kean LS, Kubisch HM, Lank S, Lyons LA, Miller GM, Nylander J, O'Connor DH, Palermo RE, Smith DG, Vallender EJ, Wiseman RW, Rogers J.

J Med Primatol. 2009 Oct;38 Suppl 1:17-23. doi: 10.1111/j.1600-0684.2009.00371.x.


Resource brief: the National Non-Human Primate DNA Bank.

Ferguson B, Capitanio J, Folks T, Hotchkiss C, Johnson Z, Kean L, Kubisch HM, Lank S, Lyons L, Miller GM, Nylander J, O'Connor D, Vallender EJ, Wiseman R.

Methods. 2009 Sep;49(1):3-4. doi: 10.1016/j.ymeth.2009.07.011.


Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.

Parikh UM, Dobard C, Sharma S, Cong ME, Jia H, Martin A, Pau CP, Hanson DL, Guenthner P, Smith J, Kersh E, Garcia-Lerma JG, Novembre FJ, Otten R, Folks T, Heneine W.

J Virol. 2009 Oct;83(20):10358-65. doi: 10.1128/JVI.01073-09. Epub 2009 Aug 5.


Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques.

Kersh EN, Luo W, Adams DR, Mitchell J, Garcia-Lerma JG, Butera S, Folks T, Otten R.

J Antimicrob Chemother. 2009 Apr;63(4):758-62. doi: 10.1093/jac/dkp008. Epub 2009 Feb 13.


Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon.

Sintasath DM, Wolfe ND, Lebreton M, Jia H, Garcia AD, Le Doux-Diffo J, Tamoufe U, Carr JK, Folks TM, Mpoudi-Ngole E, Burke DS, Heneine W, Switzer WM.

Emerg Infect Dis. 2009 Feb;15(2):175-84.


Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4.

Switzer WM, Salemi M, Qari SH, Jia H, Gray RR, Katzourakis A, Marriott SJ, Pryor KN, Wolfe ND, Burke DS, Folks TM, Heneine W.

Retrovirology. 2009 Feb 2;6:9. doi: 10.1186/1742-4690-6-9.


Coinfection with HIV-1 and simian foamy virus in West Central Africans.

Switzer WM, Garcia AD, Yang C, Wright A, Kalish ML, Folks TM, Heneine W.

J Infect Dis. 2008 May 15;197(10):1389-93. doi: 10.1086/587493.


Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques.

Kersh EN, Luo W, Adams DR, Mitchell J, Garcia-Lerma JG, Heneine W, Folks TM, Butera S, Otten RA.

AIDS Res Hum Retroviruses. 2008 Apr;24(4):543-6. doi: 10.1089/aid.2007.0222.


Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

García-Lerma JG, Otten RA, Qari SH, Jackson E, Cong ME, Masciotra S, Luo W, Kim C, Adams DR, Monsour M, Lipscomb J, Johnson JA, Delinsky D, Schinazi RF, Janssen R, Folks TM, Heneine W.

PLoS Med. 2008 Feb;5(2):e28. doi: 10.1371/journal.pmed.0050028.


Clinical and virological characterization of persistent human infection with simian foamy viruses.

Boneva RS, Switzer WM, Spira TJ, Bhullar VB, Shanmugam V, Cong ME, Lam L, Heneine W, Folks TM, Chapman LE.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1330-7. doi: 10.1089/aid.2007.0104.


Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations.

Aidoo M, Otten RA, Rodriguez V, Sariol CA, Martinez M, Kraiselburd E, Robinson H, Folks T, Butera S, Ellenberger D.

Vaccine. 2007 Aug 29;25(35):6474-81. Epub 2007 Jun 29.


Direct stringency comparison of two macaque models (single-high vs. repeat-low) for mucosal HIV transmission using an identical anti-HIV chemoprophylaxis intervention.

Subbarao S, Ramos A, Kim C, Adams D, Monsour M, Butera S, Folks T, Otten RA.

J Med Primatol. 2007 Aug;36(4-5):238-43.


Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

Subbarao S, Otten RA, Ramos A, Kim C, Jackson E, Monsour M, Adams DR, Bashirian S, Johnson J, Soriano V, Rendon A, Hudgens MG, Butera S, Janssen R, Paxton L, Greenberg AE, Folks TM.

J Infect Dis. 2006 Oct 1;194(7):904-11. Epub 2006 Aug 29.


Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.

Kim CN, Adams DR, Bashirian S, Butera S, Folks TM, Otten RA.

J Med Primatol. 2006 Aug;35(4-5):210-6.


Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis.

Switzer WM, Qari SH, Wolfe ND, Burke DS, Folks TM, Heneine W.

J Virol. 2006 Aug;80(15):7427-38.


HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.

Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Wyatt L, Hudgens MG, Kraiselburd E, Moss B, Robinson H, Folks T, Butera S.

Virology. 2006 Aug 15;352(1):216-25. Epub 2006 May 24.


Central African hunters exposed to simian immunodeficiency virus.

Kalish ML, Wolfe ND, Ndongmo CB, McNicholl J, Robbins KE, Aidoo M, Fonjungo PN, Alemnji G, Zeh C, Djoko CF, Mpoudi-Ngole E, Burke DS, Folks TM.

Emerg Infect Dis. 2005 Dec;11(12):1928-30.


Divergent HIV and simian immunodeficiency virus surveillance, Zaire.

Schaefer A, Robbins KE, Nzilambi EN, St Louis ME, Quinn TC, Folks TM, Kalish ML, Pieniazek D.

Emerg Infect Dis. 2005 Sep;11(9):1446-8.


Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.

Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM.

Proc Natl Acad Sci U S A. 2005 May 31;102(22):7994-9. Epub 2005 May 23.


Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections.

Zeh C, Pieniazek D, Agwale SM, Robbins KE, Odama L, Sani-Gwarzo N, Gboun MS, Inyang US, Folks TM, Wambebe C, Kalish ML.

AIDS Res Hum Retroviruses. 2005 Jan;21(1):17-27.


Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.

Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, Lee K, Grohskopf LA, Monsour M, Butera S, Folks TM.

J Infect Dis. 2005 Jan 15;191(2):164-73. Epub 2004 Dec 9.


New multiple antigenic peptide-based enzyme immunoassay for detection of simian immunodeficiency virus infection in nonhuman primates and humans.

Ndongmo CB, Switzer WM, Pau CP, Zeh C, Schaefer A, Pieniazek D, Folks TM, Kalish ML.

J Clin Microbiol. 2004 Nov;42(11):5161-9.


Xenotransplantation and risks of zoonotic infections.

Boneva RS, Folks TM.

Ann Med. 2004;36(7):504-17. Review. Erratum in: Ann Med. 2004;36(8):640.


Recombinant viruses and early global HIV-1 epidemic.

Kalish ML, Robbins KE, Pieniazek D, Schaefer A, Nzilambi N, Quinn TC, St Louis ME, Youngpairoj AS, Phillips J, Jaffe HW, Folks TM.

Emerg Infect Dis. 2004 Jul;10(7):1227-34.


Chronic HIV-2 infection protects against total CD4+ cell depletion and rapid disease progression induced by SHIV89.6p challenge.

Otten RA, Adams DR, Kim CN, Pullium JK, Sawyer T, Jackson E, Folks TM, Butera S.

AIDS. 2004 May 21;18(8):1127-35.


Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor.

Phelps R, Robbins K, Liberti T, Machuca A, Leparc G, Chamberland M, Kalish M, Hewlett I, Folks T, Lee LM, McKenna M.

Transfusion. 2004 Jun;44(6):929-33.


Naturally acquired simian retrovirus infections in central African hunters.

Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, Prosser AT, Torimiro JN, Wright A, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Heneine W.

Lancet. 2004 Mar 20;363(9413):932-7.


Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.

Witvrouw M, Pannecouque C, Switzer WM, Folks TM, De Clercq E, Heneine W.

Antivir Ther. 2004 Feb;9(1):57-65.


Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates.

Switzer WM, Bhullar V, Shanmugam V, Cong ME, Parekh B, Lerche NW, Yee JL, Ely JJ, Boneva R, Chapman LE, Folks TM, Heneine W.

J Virol. 2004 Mar;78(6):2780-9.


Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms.

Ellenberger D, Li B, Smith J, Yi H, Folks T, Robinson H, Butera S.

Virology. 2004 Feb 5;319(1):118-30.


New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand.

Ramos A, Nguyen L, Hu DJ, Vanichseni S, Choopanya K, Young NL, Tappero JW, Mastro TD, Folks TM, Subbarao S.

AIDS Res Hum Retroviruses. 2003 Aug;19(8):667-74.


Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.

Cummins JE Jr, Villanueva JM, Evans-Strickfaden T, Sesay SM, Abner SR, Bush TJ, Green TA, Lennox JL, Wright T, Folks TM, Hart CE, Dezzutti CS.

J Clin Microbiol. 2003 Sep;41(9):4081-8.


Human infection with foamy viruses.

Heneine W, Schweizer M, Sandstrom P, Folks T.

Curr Top Microbiol Immunol. 2003;277:181-96. Review.


Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development.

Ellenberger DL, Li B, Lupo LD, Owen SM, Nkengasong J, Kadio-Morokro MS, Smith J, Robinson H, Ackers M, Greenberg A, Folks T, Butera S.

Virology. 2002 Oct 10;302(1):155-63.


Molecular analysis in support of an investigation of a cluster of HIV-1-infected women.

Robbins KE, Weidle PJ, Brown TM, Saekhou AM, Coles B, Holmberg SD, Folks TM, Kalish ML.

AIDS Res Hum Retroviruses. 2002 Oct 10;18(15):1157-61.


Simian foamy virus infection in a blood donor.

Boneva RS, Grindon AJ, Orton SL, Switzer WM, Shanmugam V, Hussain AI, Bhullar VB, Chamberland ME, Heneine W, Folks TM, Chapman LE.

Transfusion. 2002 Jul;42(7):886-91.


Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users.

Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, Choopanya K, Callahan M, Young NL, McNicholl J, Mastro TD, Folks TM, Subbarao S.

J Virol. 2002 Aug;76(15):7444-52.


Chronic immune stimulation accelerates SIV-induced disease progression.

Villinger F, Rowe T, Parekh BS, Green TA, Mayne AE, Grimm B, McClure HM, Lackner AA, Dailey PJ, Ansari AA, Folks TM.

J Med Primatol. 2001 Oct;30(5):254-9.


Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features.

Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Lyonga EJ, Nkengasong JN, Lal RB, Rayfield M, Kalish ML, Folks TM, Pieniazek D.

J Clin Microbiol. 2002 Mar;40(3):837-45.


Facilitated detection of adventitious agents using genetically engineered cell lines.

Sandstrom PA, Folks TM.

Dev Biol (Basel). 2001;106:375-8; discussion 379-80.


Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Lawn SD, Butera ST, Folks TM.

Clin Microbiol Rev. 2001 Oct;14(4):753-77, table of contents. Review.


Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1.

Butera ST, Pisell TL, Limpakarnjanarat K, Young NL, Hodge TW, Mastro TD, Folks TM.

AIDS Res Hum Retroviruses. 2001 May 20;17(8):735-44.


Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping.

Agwale SM, Robbins KE, Odama L, Saekhou A, Zeh C, Edubio A, Njoku OM, Sani-Gwarzo N, Gboun MF, Gao F, Reitz M, Hone D, Folks TM, Pieniazek D, Wambebe C, Kalish ML.

J Clin Microbiol. 2001 Jun;39(6):2110-4.


Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients.

Hussain AI, Shanmugam V, Switzer WM, Tsang SX, Fadly A, Thea D, Helfand R, Bellini WJ, Folks TM, Heneine W.

Emerg Infect Dis. 2001 Jan-Feb;7(1):66-72.


Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo.

Yang C, Dash B, Hanna SL, Frances HS, Nzilambi N, Colebunders RC, St Louis M, Quinn TC, Folks TM, Lal RB.

AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):361-5.


Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission.

Pullium JK, Adams DR, Jackson E, Kim CN, Smith DK, Janssen R, Gould K, Folks TM, Butera S, Otten RA.

J Infect Dis. 2001 Apr 1;183(7):1023-30. Epub 2001 Mar 8.


Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: a comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction.

Reisler RB, Thea DM, Pliner V, Green T, Lee F, Nesheim S, Brown T, Kalish M, Folks TM, Heneine W; Perinatal AIDS Collaborative Transmission Studies (PACTS) members.

J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):93-102.


Supplemental Content

Support Center